A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients
about
Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patientsThe elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patientsValidation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.Do inflammatory markers predict prognosis in patients with synchronous colorectal cancer?Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal.Prognostic significance of neutrophil-to-lymphocyte ratio in biliary tract cancers: a systematic review and meta-analysisC-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.Peritonitis incidence was correlated with duration of peritoneal dialysis rather than leptin or neutrophil to lymphocyte (n/l) ratio in peritoneal dialysis patients.Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiationExternal validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients.Differentiation between benign and malignant ovarian masses in the preoperative period using neutrophil-to-lymphocyte and platelet-to-lymphocyte ratiosSignificance of the preoperative neutrophil-to-lymphocyte ratio in the prognosis of patients with gastric cancerDecreased pretreatment lymphocyte/monocyte ratio is associated with poor prognosis in stage Ib1-IIa cervical cancer patients who undergo radical surgeryPrognostic Significance of Preoperative Albumin-Globulin Ratio in Patients with Upper Tract Urothelial Carcinoma.Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy.Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio reliable parameters as prognostic indicators in malignant mesothelioma?Timing of chemotherapy-induced neutropenia predicts prognosis in metastatic colon cancer patients: a retrospective study in mFOLFOX6 -treated patientsPrognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: implications for clinical management.The role of neutrophil lymphocyte ratio to leverage the differential diagnosis of familial Mediterranean fever attack and acute appendicitisDerived neutrophil/lymphocyte ratio predicts gemcitabine therapy outcome in unresectable pancreatic cancerActivated systemic inflammatory response at diagnosis reduces lymph node count in colonic carcinoma.Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte.Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patientsValidation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients.The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma.The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer.Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma.Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer.Preoperative Albumin to Globulin Ratio (AGR) as Prognostic Factor in Renal Cell Carcinoma.Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma.Perspectives in anaesthesia for cancer surgery.Inflammatory and redox reactions in colorectal carcinogenesis.Neutrophil-to-Lymphocyte Ratio Predicts Early Mortality in Patients with HBV-Related Decompensated Cirrhosis.Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio.Association of the Derived Neutrophil-Lymphocyte Ratio With Critical Limb Ischemia.Neutrophil-lymphocyte ratio predicts survival in patients with advanced cholangiocarcinoma on chemotherapy.Neopterin as a biomarker of immune response in cancer patients.Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases.
P2860
Q28542043-E578D7D3-341A-4AA5-AB69-0B451D42310CQ33613591-ECC735A9-668B-41FC-917F-AD5F71C3091DQ33613637-BEB21E12-E978-4D4D-9C95-77F812DA2592Q33627043-44AA097D-6766-488B-9D96-272CCF5AF025Q33816141-0DD84054-6C3B-41B4-BBE4-14819FE4FFD2Q33829684-0D26D2CC-8268-4C88-9165-542FB90529FEQ33877471-9013E515-A739-45EA-8DBB-EFC7348CE5CAQ34987986-E412868B-4472-449D-8BAC-9E7C20079BEFQ34989484-7F7CB571-CD76-416F-99CE-02BD956A4B81Q35040836-37ABA679-0208-45DC-ACB7-0CBC176932AAQ35180082-CC58E844-E4B8-4846-8F2B-8405CE325B5CQ35651537-1ABDA850-50C6-4FFE-A642-E9B61AE50EEFQ35743180-0EE32B90-99E6-4BFB-8865-86F8AAF488E6Q35872670-D1F57119-DD78-4560-BE84-259B99A3370DQ35881343-B7806341-549D-43F5-B11B-83737842ACFAQ36027639-FA1EF037-DDAF-4C7F-A3F5-4EE49E50FB7BQ36334640-7DA04939-E5F7-4145-800A-A242F51899C1Q36545358-69C615B2-59D2-40D2-BC1D-0AD6DFC05A86Q36638119-18D97DA7-98EA-4C98-952D-732BDDEAC99EQ36825610-521355DF-8244-4612-B8BA-8AEFCC10DEB7Q37166707-100221F7-5FFB-4216-ACBA-78296A12BE0AQ37175931-9CA2AFD4-D014-4F00-B83A-2421CB56F27BQ37279275-E8A009D3-C317-42D0-B325-BF5BAB2681FBQ37459643-89CED2F2-D5DE-48F5-BF66-F0EA95FB7A80Q37507473-24E18456-4A99-40FA-9266-93DBE56EE843Q37507488-81AB8523-CBFA-4EA0-BC4B-9CAFF372D60CQ37588227-BA9095AF-652B-484C-8279-02C9B04AD2BDQ37624508-BCAF5CB5-7322-44EF-8127-D878B73EB783Q37667797-B3C00428-18AB-4A3E-891F-1790253A46D7Q37745835-32CF3339-A8CB-4A55-9430-87929FC28AA0Q38146832-F1938244-B94C-4CA1-8B73-4B4798F118F6Q38366373-39AFEEB2-E720-4F1A-AB62-FB899C6B07C5Q38469128-56EA09BE-BDA3-4132-A947-FB39854DD15CQ39138898-5D342D9C-8090-43E6-B87A-97A011973D3EQ40235024-810E3EE1-C475-4D64-A13C-0F25D3615047Q40547023-159A32F3-980D-4F08-ABA1-097E423D161EQ40853317-59D8F1E5-1E75-46EF-B736-B3A6E79A541BQ41002124-6BE99D62-BCD4-483F-9768-0CD13D3663CBQ41050161-AFB7EC27-88F4-4957-BF9B-B4002A09C2CDQ41162196-A633674A-2D56-4253-8866-71E543072C6B
P2860
A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A derived neutrophil to lympho ...... and III colon cancer patients
@en
A derived neutrophil to lympho ...... and III colon cancer patients.
@nl
type
label
A derived neutrophil to lympho ...... and III colon cancer patients
@en
A derived neutrophil to lympho ...... and III colon cancer patients.
@nl
prefLabel
A derived neutrophil to lympho ...... and III colon cancer patients
@en
A derived neutrophil to lympho ...... and III colon cancer patients.
@nl
P2093
P2860
P356
P1476
A derived neutrophil to lympho ...... and III colon cancer patients
@en
P2093
F Arminger
G Absenger
H Samonigg
J Szkandera
M Weissmueller
R Schaberl-Moser
T Stojakovic
P2860
P2888
P304
P356
10.1038/BJC.2013.346
P407
P577
2013-07-02T00:00:00Z